Hematopoietic potential of histocompatible embryonic stem cell lines
Hematopoietic potential of histocompatible embryonic stem cell lines
批准号:
8484937
负责人:
Kitai Kim
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-25 至 2015-03-31
关键词:
AffectBloodBone MarrowCell LineCellsChildhood LeukemiaChromosome TransferChromosomes, Human, Pair 17Chromosomes, Human, Pair 6DevelopmentDiploidyES Cell LineEmbryoEpigenetic ProcessExcisionFundingGenerationsGenetic MaterialsGoalsHandHematological DiseaseHematopoiesisHematopoieticHematopoietic Stem Cell TransplantationHematopoietic stem cellsHereditary DiseaseHistocompatibility TestingHumanHybridsIn VitroInstructionLettersMajor Histocompatibility ComplexMediatingMethodsMethylationModelingModificationMusOocytesOther GeneticsPatientsPhenotypePluripotent Stem CellsResearchResearch SubjectsRoleScheduleSkinSomatic CellSourceStagingStem cellsSupplementationTechniquesTestingTherapeuticTissuesTransplantationUmbilical Cord Bloodcell typedesignembryonic stem cellhematopoietic tissue transplantationhuman tissuein vivoinduced pluripotent stem cellmorphogensnovelnuclear transferstemtooltranscription factor
中文摘要
项目概述(见说明):
英文摘要
PROJECT SUMMARY (See instructions):
The goal of this research is to create histocompatible patient specific hematopoietic stem cells, which in addition to their potential therapeutic value, will provide novel tools for in-depth study of reprogramming and differentiation. The Specific Aims of this proposal are: Specific Aims 1: Generation of histocompatible mmctES cells using microcell mediated chromosome transfer (mmct) in mouse. Specific Aim 2: Testing of hematopoietic potential in mmctES cells by in vitro and in vivo methods. The limited availability of human oocytes required for both nuclear transferred (nt) ES and parthenogenetic (p) ES cell techniques poses a significant obstacle to generating customized embryonic stem cells. Therefore, alternative methods to generate similar types of cells are needed. Generation of ES cells by oocyte free methods already has been demonstrated by fusion of somatic cells (sc) and embryonic stem (es) cells to reprogram the somatic cells. However, removal of the genetic material from the resultant tetraploid sc-es hybrid ES cells to make diploid ES cells has not been achieved. As an alternative approach, I propose microcell-mediated transfer to ES cells of mouse sc-chromosome 17 and human sc-chromosome 6, which contain the major histocompatibility complex (MHC). The resultant duplicated mouse es-chromosome 17 and human sc-chromosome 6 will then be removed to make diploid mmctES cells in mouse
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
-
批准号:9268543
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2014
-
负责人:Kitai Kim
-
依托单位:
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
-
批准号:9064044
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2014
-
负责人:Kitai Kim
-
依托单位:
A new hypothesis: role of p53 inhibitory factors in cellular reprogramming
-
批准号:8632184
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2014
-
负责人:Kitai Kim
-
依托单位:
Hematopoietic potential of histocompatible embryonic stem cell lines
-
批准号:7510675
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2008
-
负责人:Kitai Kim
-
依托单位:
Hematopoietic potential of histocompatible embryonic stem cell lines
-
批准号:8534806
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2008
-
负责人:Kitai Kim
-
依托单位:
海外基金